Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03196427

Recruitment Status : Active, not recruiting

First Posted : June 22, 2017

Last Update Posted : January 8, 2021

Sponsor:

Collaborators:

Takeda Development Center Americas, Inc.

Takeda Development Centre Europe Ltd.

Information provided by (Responsible Party):

Takeda

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	May 25, 2025
Estimated Study Completion Date :	May 25, 2025

To Top